The third project period of 18 months has been conducted successfully and accepted by the EC
In the 3rd project period in vitro experiments focused on the establishment of the transfection of low cell numbers of freshly isolated IPE cells and the development of the GMP-compliant production process. The production of the GMP-grade plasmid has been accomplished. Exploitation of developed products and publication of results made significant progress.
12. September 2017
Categories: Target AMD